FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059095761> ?p ?o ?g. }

• W2059095761 endingPage "243" @default.
• W2059095761 startingPage "235" @default.
• W2059095761 abstract "Three type-1 repeat (3TSR) domain of thrombospondin-1 is known to have anti-angiogenic effects by targeting tumor-associated endothelial cells, but its effect on tumor cells is unknown. This study explored the potential of 3TSR to target glioblastoma (GBM) cells in vitro and in vivo. We show that 3TSR upregulates death receptor (DR) 4/5 expression in a CD36-dependent manner and primes resistant GBMs to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced caspase-8/3/7 mediated apoptosis. We engineered human mesenchymal stem cells (MSC) for on-site delivery of 3TSR and a potent and secretable variant of TRAIL (S-TRAIL) in an effort to simultaneously target tumor cells and associated endothelial cells and circumvent issues of systemic delivery of drugs across the blood-brain barrier. We show that MSC-3TSR/S-TRAIL inhibits tumor growth in an expanded spectrum of GBMs. In vivo, a single administration of MSC-3TSR/S-TRAIL significantly targets both tumor cells and vascular component of GBMs, inhibits tumor progression, and extends survival of mice bearing highly vascularized GBM. The ability of 3TSR/S-TRAIL to simultaneously act on tumor cells and tumor-associated endothelial cells offers a great potential to target a broad spectrum of cancers and translate 3TSR/TRAIL therapies into clinics." @default.
• W2059095761 created "2016-06-24" @default.
• W2059095761 creator A5007309877 @default.
• W2059095761 creator A5011930120 @default.
• W2059095761 creator A5031346352 @default.
• W2059095761 creator A5034567480 @default.
• W2059095761 creator A5045294037 @default.
• W2059095761 creator A5066956197 @default.
• W2059095761 creator A5083192393 @default.
• W2059095761 date "2015-02-01" @default.
• W2059095761 modified "2023-10-13" @default.
• W2059095761 title "Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas" @default.
• W2059095761 cites W1549631663 @default.
• W2059095761 cites W1832925227 @default.
• W2059095761 cites W1910698471 @default.
• W2059095761 cites W1965735982 @default.
• W2059095761 cites W1967600348 @default.
• W2059095761 cites W1978041336 @default.
• W2059095761 cites W1979145183 @default.
• W2059095761 cites W1980441719 @default.
• W2059095761 cites W1981555633 @default.
• W2059095761 cites W1985336971 @default.
• W2059095761 cites W1988508361 @default.
• W2059095761 cites W1998728654 @default.
• W2059095761 cites W2000534793 @default.
• W2059095761 cites W2006202974 @default.
• W2059095761 cites W2010454841 @default.
• W2059095761 cites W2024059336 @default.
• W2059095761 cites W2035773336 @default.
• W2059095761 cites W2052250554 @default.
• W2059095761 cites W2052301777 @default.
• W2059095761 cites W2052824223 @default.
• W2059095761 cites W2054543474 @default.
• W2059095761 cites W2066847074 @default.
• W2059095761 cites W2069181727 @default.
• W2059095761 cites W2078747183 @default.
• W2059095761 cites W2084414268 @default.
• W2059095761 cites W2085722674 @default.
• W2059095761 cites W2096519700 @default.
• W2059095761 cites W2101099825 @default.
• W2059095761 cites W2101332957 @default.
• W2059095761 cites W2108902725 @default.
• W2059095761 cites W2109232632 @default.
• W2059095761 cites W2127207254 @default.
• W2059095761 cites W2129305290 @default.
• W2059095761 cites W2130133905 @default.
• W2059095761 cites W2131480590 @default.
• W2059095761 cites W2135030117 @default.
• W2059095761 cites W2138306378 @default.
• W2059095761 cites W2140088548 @default.
• W2059095761 cites W2141433020 @default.
• W2059095761 cites W2142561620 @default.
• W2059095761 cites W2143308874 @default.
• W2059095761 cites W2148019984 @default.
• W2059095761 cites W2148342786 @default.
• W2059095761 cites W2154563532 @default.
• W2059095761 cites W2157628203 @default.
• W2059095761 cites W2185504543 @default.
• W2059095761 cites W2264069212 @default.
• W2059095761 cites W2554429788 @default.
• W2059095761 cites W65116864 @default.
• W2059095761 doi "https://doi.org/10.1038/mt.2014.214" @default.
• W2059095761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4445617" @default.
• W2059095761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25358253" @default.
• W2059095761 hasPublicationYear "2015" @default.
• W2059095761 type Work @default.
• W2059095761 sameAs 2059095761 @default.
• W2059095761 citedByCount "41" @default.
• W2059095761 countsByYear W20590957612015 @default.
• W2059095761 countsByYear W20590957612016 @default.
• W2059095761 countsByYear W20590957612017 @default.
• W2059095761 countsByYear W20590957612018 @default.
• W2059095761 countsByYear W20590957612019 @default.
• W2059095761 countsByYear W20590957612020 @default.
• W2059095761 countsByYear W20590957612021 @default.
• W2059095761 countsByYear W20590957612022 @default.
• W2059095761 countsByYear W20590957612023 @default.
• W2059095761 crossrefType "journal-article" @default.
• W2059095761 hasAuthorship W2059095761A5007309877 @default.
• W2059095761 hasAuthorship W2059095761A5011930120 @default.
• W2059095761 hasAuthorship W2059095761A5031346352 @default.
• W2059095761 hasAuthorship W2059095761A5034567480 @default.
• W2059095761 hasAuthorship W2059095761A5045294037 @default.
• W2059095761 hasAuthorship W2059095761A5066956197 @default.
• W2059095761 hasAuthorship W2059095761A5083192393 @default.
• W2059095761 hasBestOaLocation W20590957611 @default.
• W2059095761 hasConcept C142724271 @default.
• W2059095761 hasConcept C150903083 @default.
• W2059095761 hasConcept C17991360 @default.
• W2059095761 hasConcept C190283241 @default.
• W2059095761 hasConcept C198826908 @default.
• W2059095761 hasConcept C202751555 @default.
• W2059095761 hasConcept C203014093 @default.
• W2059095761 hasConcept C207001950 @default.
• W2059095761 hasConcept C2779130545 @default.
• W2059095761 hasConcept C2780394083 @default.
• W2059095761 hasConcept C502942594 @default.
• W2059095761 hasConcept C55493867 @default.

• next